These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1826517)

  • 21. Characteristics of 5-HT3 binding sites in NG108-15, NCB-20 neuroblastoma cells and rat cerebral cortex using [3H]-quipazine and [3H]-GR65630 binding.
    Sharif NA; Wong EH; Loury DN; Stefanich E; Michel AD; Eglen RM; Whiting RL
    Br J Pharmacol; 1991 Apr; 102(4):919-25. PubMed ID: 1830236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
    Laruelle M; Vanisberg MA; Maloteaux JM
    Biol Psychiatry; 1988 Jul; 24(3):299-309. PubMed ID: 2969755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of 3H-paroxetine as a radioligand for in vivo study of 5-hydroxytryptamine uptake sites in mouse brain.
    Hashimoto K; Goromaru T
    Radioisotopes; 1990 Aug; 39(8):335-41. PubMed ID: 2146707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pitfalls in demonstrating an endogenous ligand of imipramine recognition sites.
    Lee CR; Galzin AM; Taranger MA; Langer SZ
    Biochem Pharmacol; 1987 Mar; 36(6):945-9. PubMed ID: 3032200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.
    Mellerup ET; Plenge P
    Psychopharmacology (Berl); 1986; 89(4):436-9. PubMed ID: 2944152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet [3H]paroxetine binding to 5-HT uptake sites in Alzheimer's disease.
    Andersson A; Adolfsson R; Eriksson K; Marcusson J
    Neurobiol Aging; 1991; 12(5):531-4. PubMed ID: 1837595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium dependence of [3H]paroxetine binding and 5-[3H]hydroxytryptamine uptake in rat diencephalon.
    Mann CD; Hrdina PD
    J Neurochem; 1992 Nov; 59(5):1856-61. PubMed ID: 1402927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.
    Raisman R; Cash R; Agid Y
    Neurology; 1986 Apr; 36(4):556-60. PubMed ID: 2938025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3H] sertraline binding to rat brain membranes.
    Koe BK; Lebel LA; Welch WM
    Psychopharmacology (Berl); 1990; 100(4):470-6. PubMed ID: 2138796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor.
    Gleiter CH; Nutt DJ
    Adv Alcohol Subst Abuse; 1988; 7(3-4):107-11. PubMed ID: 2975918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activity of 25 paroxetine/femoxetine structure variants in various reactions, assumed to be important for the effect of antidepressants.
    Plenge P; Mellerup ET; Honoré T; Honoré PL
    J Pharm Pharmacol; 1987 Nov; 39(11):877-82. PubMed ID: 2892909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro neurotransmitter release in an animal model of depression.
    Edwards E; Kornrich W; van Houtten P; Henn FA
    Neurochem Int; 1992 Jul; 21(1):29-35. PubMed ID: 1303140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.